4.7 Review

The Use of Mesenchymal (Skeletal) Stem Cells for Treatment of Degenerative Diseases: Current Status and Future Perspectives

Journal

JOURNAL OF CELLULAR PHYSIOLOGY
Volume 218, Issue 1, Pages 9-12

Publisher

WILEY
DOI: 10.1002/jcp.21572

Keywords

-

Funding

  1. Danish Medical Research Council
  2. Novo Nordisk Foundation
  3. Lundbeck Foundation
  4. Danish Center for Stem Cell Research

Ask authors/readers for more resources

Human bone marrow derived-mesenchymal (skeletal) stem (MSC) cells are a group of non-hematopoietic stem cells residing in the perivascular niches in bone marrow. These cells have the capacity to differentiate mainly into mesoderm-type cells such as osteoblasts, chondrocytes and adipocytes and possibly but not proven to non-mesodermal cell types. Recently, there has been an increased interest in understanding the biology of MSC due to their potential use in cell-based therapy for multiple degenerative diseases. Here, we will provide an update on the current status of these novel therapeutic opportunities.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available